Previous 10 | Next 10 |
Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2023. Financial Results Revenue Cons...
NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the 2024 Healthcare IT Virtual Conference. The conference will take pla...
2023-12-30 18:55:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-10-12 16:55:31 ET More on CRYO-CELL International Seeking Alpha’s Quant Rating on CRYO-CELL International Historical earnings data for CRYO-CELL International Financial information for CRYO-CELL International For further details see: CRYO-CELL...
Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2023. Financial Results Revenu...
2023-07-17 07:29:16 ET CRYO-CELL International press release ( NYSE: CCEL ): Q2 GAAP EPS of $0.03. Revenue of $7.77M (+1.8% Y/Y). For further details see: CRYO-CELL International GAAP EPS of $0.03, revenue of $7.77M
Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2023. Financial Results Revenue ...
2023-04-21 16:44:10 ET CRYO-CELL International press release ( NYSE: CCEL ): Q1 GAAP EPS of $0.09 beats by $0.13 . Revenue of $7.82M (+7.7% Y/Y) beats by $0.41M . For further details see: CRYO-CELL International GAAP EPS of $0.09 beats by $0.13, revenue o...
Cryo-Cell International, Inc. (NYSE American LLC: CCEL ) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2023. Financial Results Revenue ...
CRYO-CELL International press release ( NYSE: CCEL ): FY GAAP EPS of $0.33 beats by $0.20 . Revenue of $30.3M (+4.8% Y/Y) beats by $0.46M . For further details see: CRYO-CELL International GAAP EPS of $0.33 beats by $0.20, revenue of $30.3M beats by $0.46M
News, Short Squeeze, Breakout and More Instantly...
Cryo-Cell International, Inc. Company Name:
CCEL Stock Symbol:
OTCMKTS Market:
2024-05-16 10:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-06 17:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-26 23:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...